Effect of anti-transforming growth factor-β antibodies in cyclosporine-induced renal dysfunction

Muhammad Islam, James F. Burke, Tracy A. McGowan, Yanqing Zhu, Stephen R. Dunn, Peter McCue, John Kanalas, Kumar Sharma

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Background. Several experimental and clinical studies have implicated a role for transforming growth factor-β (TGF-β) in mediating the nephrotoxic effects of cyclosporine (CsA). To test this hypothesis, we administered neutralizing anti-TGF-β antibodies (α-TGF-β) in a well-described rat model of chronic CsA nephrotoxicity. Methods. We studied three groups (N = 9 per group) of adult, male Sprague-Dawley rats that received a low-salt diet (0.05% sodium). Normal controls were given vehicle subcutaneously and an alternate-day intraperitoneal injection of 3 mg of nonspecific mouse IgG (MIgG) for 28 days. The CsA group received 15 mg/kg/day of CsA subcutaneously and 3 mg of MIgG intraperitoneally on alternate days for 28 days. The CsA/α-TGF-β group received CsA and alternate-day α-TGF-β (3 mg) for 28 days. At the end of 28 days, creatinine clearance was measured by 24-hour urine collection. Histologic assessment was performed for tubulointerstitial damage and arteriolar hyalinosis. Northern analysis was performed for α1(I) collagen and TGF-β1 gene expression, and quantitative reverse transcription-polymerase chain reaction was performed to measure levels of tissue inhibitor of metalloproteinase-1 (TIMP-1), TIMP-2, plasminogen activator inhibitor-1 (PAI-1), matrix metalloproteinase-2 (MMP-2), and MMP-9. Results. CsA-treated rats had significantly lower creatinine clearance as compared with normal controls (0.43 ± 0.07 vs. 0.67 ± 0.14 mL/min, P = 0.0002), increased interstitial damage and afferent arteriolar hyalinosis (P = 0.0001), and increased α1 (I) collagen (4-fold) and TGF-β1 (2.5-fold) mRNA expression. CsA-treated rats also had significantly increased TIMP-1 (7.4-fold, P < 0.001), MMP-2, and PAI-1 (all approximately 2-fold, P < 0.02) and decreased MMP-9 (85% reduction, P < 0.001) as compared with controls. Treatment with α-TGF-β in CsA-treated rats significantly prevented the reduction in creatinine clearance (0.58 ± 0.03 mL/min, P = 0.009 vs. CsA alone), the increase in afferent arteriolar hyalinosis (P < 0.05 vs. CsA alone), normalized α1(I) collagen mRNA levels, and attenuated CsA effects on TGF-β1, TIMP-1, and MMP-9. Conclusions. In this rat model of CsA-induced nephrotoxicity, renal insufficiency and characteristic histologic changes are associated with altered expression of matrix and matrix-regulating molecules. Based on our results with α-TGF-β antibodies, many but not all of these nephrotoxic effects of CsA are mediated by TGF-β.

Original languageEnglish (US)
Pages (from-to)498-506
Number of pages9
JournalKidney International
Volume59
Issue number2
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Transforming Growth Factors
Cyclosporine
Kidney
Antibodies
Tissue Inhibitor of Metalloproteinase-1
Matrix Metalloproteinases
Creatinine
Collagen
Matrix Metalloproteinase 2
Plasminogen Activator Inhibitor 1
Immunoglobulin G
Sodium-Restricted Diet
Tissue Inhibitor of Metalloproteinase-2
Urine Specimen Collection
Messenger RNA
Intraperitoneal Injections
Reverse Transcription
Renal Insufficiency
Sprague Dawley Rats
Sodium

Keywords

  • Immunosuppression
  • Kidney failure
  • Matrix metalloproteinase
  • Nephrotoxicity
  • TIMP-1
  • Type I collagen

ASJC Scopus subject areas

  • Nephrology

Cite this

Effect of anti-transforming growth factor-β antibodies in cyclosporine-induced renal dysfunction. / Islam, Muhammad; Burke, James F.; McGowan, Tracy A.; Zhu, Yanqing; Dunn, Stephen R.; McCue, Peter; Kanalas, John; Sharma, Kumar.

In: Kidney International, Vol. 59, No. 2, 01.01.2001, p. 498-506.

Research output: Contribution to journalArticle

Islam, Muhammad ; Burke, James F. ; McGowan, Tracy A. ; Zhu, Yanqing ; Dunn, Stephen R. ; McCue, Peter ; Kanalas, John ; Sharma, Kumar. / Effect of anti-transforming growth factor-β antibodies in cyclosporine-induced renal dysfunction. In: Kidney International. 2001 ; Vol. 59, No. 2. pp. 498-506.
@article{997b106acc184571a8cfbba6eff2e8d5,
title = "Effect of anti-transforming growth factor-β antibodies in cyclosporine-induced renal dysfunction",
abstract = "Background. Several experimental and clinical studies have implicated a role for transforming growth factor-β (TGF-β) in mediating the nephrotoxic effects of cyclosporine (CsA). To test this hypothesis, we administered neutralizing anti-TGF-β antibodies (α-TGF-β) in a well-described rat model of chronic CsA nephrotoxicity. Methods. We studied three groups (N = 9 per group) of adult, male Sprague-Dawley rats that received a low-salt diet (0.05{\%} sodium). Normal controls were given vehicle subcutaneously and an alternate-day intraperitoneal injection of 3 mg of nonspecific mouse IgG (MIgG) for 28 days. The CsA group received 15 mg/kg/day of CsA subcutaneously and 3 mg of MIgG intraperitoneally on alternate days for 28 days. The CsA/α-TGF-β group received CsA and alternate-day α-TGF-β (3 mg) for 28 days. At the end of 28 days, creatinine clearance was measured by 24-hour urine collection. Histologic assessment was performed for tubulointerstitial damage and arteriolar hyalinosis. Northern analysis was performed for α1(I) collagen and TGF-β1 gene expression, and quantitative reverse transcription-polymerase chain reaction was performed to measure levels of tissue inhibitor of metalloproteinase-1 (TIMP-1), TIMP-2, plasminogen activator inhibitor-1 (PAI-1), matrix metalloproteinase-2 (MMP-2), and MMP-9. Results. CsA-treated rats had significantly lower creatinine clearance as compared with normal controls (0.43 ± 0.07 vs. 0.67 ± 0.14 mL/min, P = 0.0002), increased interstitial damage and afferent arteriolar hyalinosis (P = 0.0001), and increased α1 (I) collagen (4-fold) and TGF-β1 (2.5-fold) mRNA expression. CsA-treated rats also had significantly increased TIMP-1 (7.4-fold, P < 0.001), MMP-2, and PAI-1 (all approximately 2-fold, P < 0.02) and decreased MMP-9 (85{\%} reduction, P < 0.001) as compared with controls. Treatment with α-TGF-β in CsA-treated rats significantly prevented the reduction in creatinine clearance (0.58 ± 0.03 mL/min, P = 0.009 vs. CsA alone), the increase in afferent arteriolar hyalinosis (P < 0.05 vs. CsA alone), normalized α1(I) collagen mRNA levels, and attenuated CsA effects on TGF-β1, TIMP-1, and MMP-9. Conclusions. In this rat model of CsA-induced nephrotoxicity, renal insufficiency and characteristic histologic changes are associated with altered expression of matrix and matrix-regulating molecules. Based on our results with α-TGF-β antibodies, many but not all of these nephrotoxic effects of CsA are mediated by TGF-β.",
keywords = "Immunosuppression, Kidney failure, Matrix metalloproteinase, Nephrotoxicity, TIMP-1, Type I collagen",
author = "Muhammad Islam and Burke, {James F.} and McGowan, {Tracy A.} and Yanqing Zhu and Dunn, {Stephen R.} and Peter McCue and John Kanalas and Kumar Sharma",
year = "2001",
month = "1",
day = "1",
doi = "10.1046/j.1523-1755.2001.059002498.x",
language = "English (US)",
volume = "59",
pages = "498--506",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Effect of anti-transforming growth factor-β antibodies in cyclosporine-induced renal dysfunction

AU - Islam, Muhammad

AU - Burke, James F.

AU - McGowan, Tracy A.

AU - Zhu, Yanqing

AU - Dunn, Stephen R.

AU - McCue, Peter

AU - Kanalas, John

AU - Sharma, Kumar

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Background. Several experimental and clinical studies have implicated a role for transforming growth factor-β (TGF-β) in mediating the nephrotoxic effects of cyclosporine (CsA). To test this hypothesis, we administered neutralizing anti-TGF-β antibodies (α-TGF-β) in a well-described rat model of chronic CsA nephrotoxicity. Methods. We studied three groups (N = 9 per group) of adult, male Sprague-Dawley rats that received a low-salt diet (0.05% sodium). Normal controls were given vehicle subcutaneously and an alternate-day intraperitoneal injection of 3 mg of nonspecific mouse IgG (MIgG) for 28 days. The CsA group received 15 mg/kg/day of CsA subcutaneously and 3 mg of MIgG intraperitoneally on alternate days for 28 days. The CsA/α-TGF-β group received CsA and alternate-day α-TGF-β (3 mg) for 28 days. At the end of 28 days, creatinine clearance was measured by 24-hour urine collection. Histologic assessment was performed for tubulointerstitial damage and arteriolar hyalinosis. Northern analysis was performed for α1(I) collagen and TGF-β1 gene expression, and quantitative reverse transcription-polymerase chain reaction was performed to measure levels of tissue inhibitor of metalloproteinase-1 (TIMP-1), TIMP-2, plasminogen activator inhibitor-1 (PAI-1), matrix metalloproteinase-2 (MMP-2), and MMP-9. Results. CsA-treated rats had significantly lower creatinine clearance as compared with normal controls (0.43 ± 0.07 vs. 0.67 ± 0.14 mL/min, P = 0.0002), increased interstitial damage and afferent arteriolar hyalinosis (P = 0.0001), and increased α1 (I) collagen (4-fold) and TGF-β1 (2.5-fold) mRNA expression. CsA-treated rats also had significantly increased TIMP-1 (7.4-fold, P < 0.001), MMP-2, and PAI-1 (all approximately 2-fold, P < 0.02) and decreased MMP-9 (85% reduction, P < 0.001) as compared with controls. Treatment with α-TGF-β in CsA-treated rats significantly prevented the reduction in creatinine clearance (0.58 ± 0.03 mL/min, P = 0.009 vs. CsA alone), the increase in afferent arteriolar hyalinosis (P < 0.05 vs. CsA alone), normalized α1(I) collagen mRNA levels, and attenuated CsA effects on TGF-β1, TIMP-1, and MMP-9. Conclusions. In this rat model of CsA-induced nephrotoxicity, renal insufficiency and characteristic histologic changes are associated with altered expression of matrix and matrix-regulating molecules. Based on our results with α-TGF-β antibodies, many but not all of these nephrotoxic effects of CsA are mediated by TGF-β.

AB - Background. Several experimental and clinical studies have implicated a role for transforming growth factor-β (TGF-β) in mediating the nephrotoxic effects of cyclosporine (CsA). To test this hypothesis, we administered neutralizing anti-TGF-β antibodies (α-TGF-β) in a well-described rat model of chronic CsA nephrotoxicity. Methods. We studied three groups (N = 9 per group) of adult, male Sprague-Dawley rats that received a low-salt diet (0.05% sodium). Normal controls were given vehicle subcutaneously and an alternate-day intraperitoneal injection of 3 mg of nonspecific mouse IgG (MIgG) for 28 days. The CsA group received 15 mg/kg/day of CsA subcutaneously and 3 mg of MIgG intraperitoneally on alternate days for 28 days. The CsA/α-TGF-β group received CsA and alternate-day α-TGF-β (3 mg) for 28 days. At the end of 28 days, creatinine clearance was measured by 24-hour urine collection. Histologic assessment was performed for tubulointerstitial damage and arteriolar hyalinosis. Northern analysis was performed for α1(I) collagen and TGF-β1 gene expression, and quantitative reverse transcription-polymerase chain reaction was performed to measure levels of tissue inhibitor of metalloproteinase-1 (TIMP-1), TIMP-2, plasminogen activator inhibitor-1 (PAI-1), matrix metalloproteinase-2 (MMP-2), and MMP-9. Results. CsA-treated rats had significantly lower creatinine clearance as compared with normal controls (0.43 ± 0.07 vs. 0.67 ± 0.14 mL/min, P = 0.0002), increased interstitial damage and afferent arteriolar hyalinosis (P = 0.0001), and increased α1 (I) collagen (4-fold) and TGF-β1 (2.5-fold) mRNA expression. CsA-treated rats also had significantly increased TIMP-1 (7.4-fold, P < 0.001), MMP-2, and PAI-1 (all approximately 2-fold, P < 0.02) and decreased MMP-9 (85% reduction, P < 0.001) as compared with controls. Treatment with α-TGF-β in CsA-treated rats significantly prevented the reduction in creatinine clearance (0.58 ± 0.03 mL/min, P = 0.009 vs. CsA alone), the increase in afferent arteriolar hyalinosis (P < 0.05 vs. CsA alone), normalized α1(I) collagen mRNA levels, and attenuated CsA effects on TGF-β1, TIMP-1, and MMP-9. Conclusions. In this rat model of CsA-induced nephrotoxicity, renal insufficiency and characteristic histologic changes are associated with altered expression of matrix and matrix-regulating molecules. Based on our results with α-TGF-β antibodies, many but not all of these nephrotoxic effects of CsA are mediated by TGF-β.

KW - Immunosuppression

KW - Kidney failure

KW - Matrix metalloproteinase

KW - Nephrotoxicity

KW - TIMP-1

KW - Type I collagen

UR - http://www.scopus.com/inward/record.url?scp=0035132655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035132655&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.2001.059002498.x

DO - 10.1046/j.1523-1755.2001.059002498.x

M3 - Article

VL - 59

SP - 498

EP - 506

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 2

ER -